Abstract
A substantial fraction of the human population suffers from chronic pain states, which often cannot be sufficiently treated with existing drugs. This calls for alternative targets and strategies for the development of novel analgesics. There is substantial evidence that the G protein-coupled GABAB receptor is involved in the processing of pain signals and thus has long been considered a valuable target for the generation of analgesics to treat chronic pain. In this review, the contribution of GABAB receptors to the generation and modulation of pain signals, their involvement in chronic pain states as well as their target suitability for the development of novel analgesics is discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Albrecht PJ, Rice FL (2010) Role of small-fiber afferents in pain mechanisms with implications on diagnosis and treatment. Curr Pain Headache Rep 14(3):179–188. https://doi.org/10.1007/s11916-010-0105-y
Almeida A, Storkson R, Lima D, Hole K, Tjolsen A (1999) The medullary dorsal reticular nucleus facilitates pain behaviour induced by formalin in the rat. Eur J Neurosci 11(1):110–122
Almeida A, Tjolsen A, Lima D, Coimbra A, Hole K (1996) The medullary dorsal reticular nucleus facilitates acute nociception in the rat. Brain Res Bull 39(1):7–15
Andrade R, Malenka RC, Nicoll RA (1986) A G protein couples serotonin and GABAB receptors to the same channels in hippocampus. Science 234(4781):1261–1265
Ataka T, Kumamoto E, Shimoji K, Yoshimura M (2000) Baclofen inhibits more effectively C-afferent than Aδ-afferent glutamatergic transmission in substantia gelatinosa neurons of adult rat spinal cord slices. Pain 86(3):273–282
Aziz-Donnelly A, Harrison TB (2017) Update of HIV-associated sensory neuropathies. Curr Treat Options Neurol 19(10):36. https://doi.org/10.1007/s11940-017-0472-3
Bai HP, Liu P, Wu YM, Guo WY, Guo YX, Wang XL (2014) Activation of spinal GABAB receptors normalizes N-methyl-D-aspartate receptor in diabetic neuropathy. J Neurol Sci 341(1–2):68–72. https://doi.org/10.1016/j.jns.2014.04.002
Basbaum AI, Bautista DM, Scherrer G, Julius D (2009) Cellular and molecular mechanisms of pain. Cell 139(2):267–284. https://doi.org/10.1016/j.cell.2009.09.028
Bassi GS, do Malvar CD, Cunha TM, Cunha FQ, Kanashiro A (2016) Spinal GABAB receptor modulates neutrophil recruitment to the knee joint in zymosan-induced arthritis. Naunyn Schmiedebergs Arch Pharmacol 389(8):851–861. https://doi.org/10.1007/s00210-016-1248-0
Bean BP (1989) Neurotransmitter inhibition of neuronal calcium currents by changes in channel voltage dependence. Nature 340(6229):153–156. https://doi.org/10.1038/340153a0
Bell A (2018) The neurobiology of acute pain. Vet J 237:55–62. https://doi.org/10.1016/j.tvjl.2018.05.004
Benke D, Honer M, Michel C, Bettler B, Mohler H (1999) γ-Aminobutyric acid type B receptor splice variant proteins GBR1a and GBR1b are both associated with GBR2 in situ and display differential regional and subcellular distribution. J Biol Chem 274:27323–27330
Bennett DL, Woods CG (2014) Painful and painless channelopathies. Lancet Neurol 13(6):587–599. https://doi.org/10.1016/s1474-4422(14)70024-9
Berecki G, McArthur JR, Cuny H, Clark RJ, Adams DJ (2014) Differential Cav2.1 and Cav2.3 channel inhibition by baclofen and alpha-conotoxin Vc1.1 via GABAB receptor activation. J Gen Physiol 143(4):465–479. https://doi.org/10.1085/jgp.201311104
Brennan PM, Whittle IR (2008) Intrathecal baclofen therapy for neurological disorders: a sound knowledge base but many challenges remain. Br J Neurosurg 22(4):508–519. https://doi.org/10.1080/02688690802233364
Brewer CL, Baccei ML (2018) Enhanced Postsynaptic GABAB Receptor Signaling in Adult Spinal Projection Neurons after Neonatal Injury. Neuroscience 384:329–339. https://doi.org/10.1016/j.neuroscience.2018.05.046
Brusberg M, Ravnefjord A, Martinsson R, Larsson H, Martinez V, Lindström E (2009) The GABAB receptor agonist, baclofen, and the positive allosteric modulator, CGP7930, inhibit visceral pain-related responses to colorectal distension in rats. Neuropharmacology 56(2):362–367
Buritova J, Chapman V, Honore P, Besson JM (1996) The contribution of GABAB receptor-mediated events to inflammatory pain processing: carrageenan oedema and associated spinal c-Fos expression in the rat. Neuroscience 73(2):487–496
Bussieres N, El Manira A (1999) GABAB receptor activation inhibits N- and P/Q-type calcium channels in cultured lamprey sensory neurons. Brain Res 847(2):175–185
Callaghan B, Haythornthwaite A, Berecki G, Clark RJ, Craik DJ, Adams DJ (2008) Analgesic alpha-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in rat sensory neurons via GABAB receptor activation. J Neurosci 28(43):10943–10951. https://doi.org/10.1523/jneurosci.3594-08.2008
Castro-Lopes JM, Malcangio M, Pan BH, Bowery NG (1995) Complex changes of GABAA and GABAB receptor binding in the spinal cord dorsal horn following peripheral inflammation or neurectomy. Brain Res 679(2):289–297
Castro AR, Morgado C, Lima D, Tavares I (2006) Differential expression of NK1 and GABAB receptors in spinal neurones projecting to antinociceptive or pronociceptive medullary centres. Brain Res Bull 69(3):266–275. https://doi.org/10.1016/j.brainresbull.2005.12.004
Castro J, Harrington AM, Garcia-Caraballo S, Maddern J, Grundy L, Zhang J, Page G, Miller PE, Craik DJ, Adams DJ, Brierley SM (2017) α-Conotoxin Vc1.1 inhibits human dorsal root ganglion neuroexcitability and mouse colonic nociception via GABAB receptors. Gut 66(6):1083–1094. https://doi.org/10.1136/gutjnl-2015-310971
Charles KJ, Evans ML, Robbins MJ, Calver AR, Leslie RA, Pangalos MN (2001) Comparative immunohistochemical localisation of GABAB1a, GABAB1b and GABAB2 subunits in rat brain, spinal cord and dorsal root ganglion. Neuroscience 106(3):447–467
Chen G, van den Pol AN (1998) Presynaptic GABAB autoreceptor modulation of P/Q-type calcium channels and GABA release in rat suprachiasmatic nucleus neurons. J Neurosci 18(5):1913–1922
Chen Q, Shao C, Zhou H, Ma R, Jiang P, Yang K (2017) Differential sensitivity of presynaptic and postsynaptic GABAB receptors in rat ventrolateral periaqueductal gray. Neuroreport 28(18):1221–1224. https://doi.org/10.1097/wnr.0000000000000906
Cuny H, de Faoite A, Huynh TG, Yasuda T, Berecki G, Adams DJ (2012) γ-Aminobutyric acid type B (GABAΒ) receptor expression is needed for inhibition of N-type (Cav2.2) calcium channels by analgesic alpha-conotoxins. J Biol Chem 287(28):23948–23957. https://doi.org/10.1074/jbc.M112.342998
Davis MP (2018) Cancer-Related Neuropathic Pain: Review and Selective Topics. Hematol Oncol Clin North Am 32(3):417–431. https://doi.org/10.1016/j.hoc.2018.01.005
Delaney AJ, Crane JW (2016) Presynaptic GABAB receptors reduce transmission at parabrachial synapses in the lateral central amygdala by inhibiting N-type calcium channels. Sci Rep 6:19255. https://doi.org/10.1038/srep19255
Desarmenien M, Feltz P, Occhipinti G, Santangelo F, Schlichter R (1984) Coexistence of GABAA and GABAB receptors on A delta and C primary afferents. Br J Pharmacol 81(2):327–333. https://doi.org/10.1111/j.1476-5381.1984.tb10082.x
Dias QM, Prado WA (2016) The lesion of dorsolateral funiculus changes the antiallodynic effect of the intrathecal muscimol and baclofen in distinct phases of neuropathic pain induced by spinal nerve ligation in rats. Brain Res Bull 124:103–115. https://doi.org/10.1016/j.brainresbull.2016.04.001
Dirig DM, Yaksh TL (1995) Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat-formalin model. J Pharmacol Exp Ther 275(1):219–227
Duan B, Cheng L, Bourane S, Britz O, Padilla C, Garcia-Campmany L, Krashes M, Knowlton W, Velasquez T, Ren X, Ross S, Lowell BB, Wang Y, Goulding M, Ma Q (2014) Identification of spinal circuits transmitting and gating mechanical pain. Cell 159(6):1417–1432. https://doi.org/10.1016/j.cell.2014.11.003
Eaton MJ, Plunkett JA, Karmally S, Martinez MA, Montanez K (1998) Changes in GAD- and GABA- immunoreactivity in the spinal dorsal horn after peripheral nerve injury and promotion of recovery by lumbar transplant of immortalized serotonergic precursors. J Chem Neuroanat 16(1):57–72
Engle MP, Gassman M, Sykes KT, Bettler B, Hammond DL (2006) Spinal nerve ligation does not alter the expression or function of GABAB receptors in spinal cord and dorsal root ganglia of the rat. Neuroscience 138(4):1277–1287
Engle MP, Merrill MA, Marquez De Prado B, Hammond DL (2012) Spinal nerve ligation decreases γ-aminobutyric acidB receptors on specific populations of immunohistochemically identified neurons in L5 dorsal root ganglion of the rat. J Comp Neurol 520(8):1663–1677. https://doi.org/10.1002/cne.23005
Enna SJ, McCarson KE (2006) The role of GABA in the mediation and perception of pain. Adv Pharmacol 54:1–27
Foster E, Wildner H, Tudeau L, Haueter S, Ralvenius WT, Jegen M, Johannssen H, Hosli L, Haenraets K, Ghanem A, Conzelmann KK, Bosl M, Zeilhofer HU (2015) Targeted ablation, silencing, and activation establish glycinergic dorsal horn neurons as key components of a spinal gate for pain and itch. Neuron 85(6):1289–1304. https://doi.org/10.1016/j.neuron.2015.02.028
Fritschy JM, Meskenaite V, Weinmann O, Honer M, Benke D, Mohler H (1999) GABAB receptor splice variants GB1a and GB1b in rat brain: developmental regulation, cellular distribution and extrasynaptic localization. Eur J Neurosci 11(3):761–768
Fritschy JM, Sidler C, Parpan F, Gassmann M, Kaupmann K, Bettler B, Benke D (2004) Independent maturation of the GABAB receptor subunits GABAB1 and GABAB2 during postnatal development in rodent brain. J Comp Neurol 477(3):235–252
Froestl W (2010) Novel GABAB receptor positive modulators: a patent survey. Expert Opin Ther Pat 20(8):1007–1017
Fromm GH, Terrence CF (1987) Comparison of L-baclofen and racemic baclofen in trigeminal neuralgia. Neurology 37(11):1725–1728. https://doi.org/10.1212/wnl.37.11.1725
Fromm GH, Terrence CF, Chattha AS (1984) Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol 15(3):240–244. https://doi.org/10.1002/ana.410150306
Fuchs PN, Peng YB, Boyette-Davis JA, Uhelski ML (2014) The anterior cingulate cortex and pain processing. Front Integr Neurosci 8:35. https://doi.org/10.3389/fnint.2014.00035
Gaillard S, Lo Re L, Mantilleri A, Hepp R, Urien L, Malapert P, Alonso S, Deage M, Kambrun C, Landry M, Low SA, Alloui A, Lambolez B, Scherrer G, Le Feuvre Y, Bourinet E, Moqrich A (2014) GINIP, a G-interacting protein, functions as a key modulator of peripheral GABA receptor-mediated analgesia. Neuron 84:123–136. https://doi.org/10.1016/j.neuron.2014.08.056
Gangadharan V, Agarwal N, Brugger S, Tegeder I, Bettler B, Kuner R, Kurejova M (2009) Conditional gene deletion reveals functional redundancy of GABAB receptors in peripheral nociceptors in vivo. Mol Pain 5:68
Gangadharan V, Kuner R (2013) Pain hypersensitivity mechanisms at a glance. Dis Model Mech 6(4):889–895. https://doi.org/10.1242/dmm.011502
Gassmann M, Bettler B (2012) Regulation of neuronal GABAB receptor functions by subunit composition. Nat Rev Neurosci 13(6):380–394. https://doi.org/10.1038/nrn3249
Gassmann M, Shaban H, Vigot R, Sansig G, Haller C, Barbieri S, Humeau Y, Schuler V, Müller M, Kinzel B, Klebs K, Schmutz M, Froestl W, Heid J, Kelly PH, Gentry C, Jaton AL, Van der Putten H, Mombereau C, Lecourtier L, Mosbacher J, Cryan JF, Fritschy JM, Lüthi A, Kaupmann K, Bettler B (2004) Redistribution of GABAB1 protein and atypical GABAB responses in GABAB2-deficient mice. J Neurosci 24(27):6086–6097
Gatscher S, Becker R, Uhle E, Bertalanffy H (2002) Combined intrathecal baclofen and morphine infusion for the treatment of spasticity related pain and central deafferentiation pain. Acta Neurochir Suppl 79:75–76
Goto S, Taira T, Horisawa S, Yokote A, Sasaki T, Okada Y (2013) Spinal cord stimulation and intrathecal baclofen therapy: combined neuromodulation for treatment of advanced complex regional pain syndrome. Stereotact Funct Neurosurg 91(6):386–391. https://doi.org/10.1159/000350022
Greif GJ, Sodickson DL, Bean BP, Neer EJ, Mende U (2000) Altered regulation of potassium and calcium channels by GABAB and adenosine receptors in hippocampal neurons from mice lacking Gαo. J Neurophysiol 83(2):1010–1018
Guetg N, Aziz SA, Holbro N, Turecek R, Rose T, Seddik R, Gassmann M, Moes S, Jenoe P, Oertner TG, Casanova E, Bettler B (2010) NMDA receptor-dependent GABAB receptor internalization via CaMKII phosphorylation of serine 867 in GABAB1. Proc Natl Acad Sci U S A 107(31):13924–13929
Guyon A, Kussrow A, Olmsted IR, Sandoz G, Bornhop DJ, Nahon JL (2013) Baclofen and other GABAB receptor agents are allosteric modulators of the CXCL12 chemokine receptor CXCR4. J Neurosci 33(28):11643–11654. https://doi.org/10.1523/jneurosci.6070-11.2013
Gwak YS, Hulsebosch CE (2011) GABA and central neuropathic pain following spinal cord injury. Neuropharmacology 60(5):799–808. https://doi.org/10.1016/j.neuropharm.2010.12.030
Gwak YS, Tan HY, Nam TS, Paik KS, Hulsebosch CE, Leem JW (2006) Activation of spinal GABA receptors attenuates chronic central neuropathic pain after spinal cord injury. J Neurotrauma 23(7):1111–1124. https://doi.org/10.1089/neu.2006.23.1111
Hammond DL (1997) Inhibitory neurotransmitters and nociception: role of GABA and glycine. In: Dickenson A, Besson JM (eds) The pharmacology of pain. Springer, Berlin, pp 361–383. https://doi.org/10.1007/978-3-642-60777-6_14
Hanack C, Moroni M, Lima WC, Wende H, Kirchner M, Adelfinger L, Schrenk-Siemens K, Tappe-Theodor A, Wetzel C, Kuich PH, Gassmann M, Roggenkamp D, Bettler B, Lewin GR, Selbach M, Siemens J (2015) GABA blocks pathological but not acute TRPV1 pain signals. Cell 160(4):759–770. https://doi.org/10.1016/j.cell.2015.01.022
Hang LH, Yang JP, Shao DH, Chen Z, Wang H (2013) Involvement of spinal PKA/CREB signaling pathway in the development of bone cancer pain. Pharmacol Rep 65(3):710–716
Harmer JP, Larson BS (2002) Pain relief from baclofen analgesia in a neuropathic pain patient who failed opioid and pharmacotherapy: case report. J Pain Palliat Care Pharmacother 16(3):61–64
Hawrot E, Xiao Y, Shi QL, Norman D, Kirkitadze M, Barlow PN (1998) Demonstration of a tandem pair of complement protein modules in GABAB receptor 1a. FEBS Lett 432(3):103–108
Herman RM, D'Luzansky SC, Ippolito R (1992) Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study. Clin J Pain 8(4):338–345
Hosny A, Simopoulos T, Collins B (2004) Response of intractable post herpetic neuralgia to intrathecal baclofen. Pain Physician 7(3):345–347
Hu C, Zhang G, Zhao YT (2014) Fucoidan attenuates the existing allodynia and hyperalgesia in a rat model of neuropathic pain. Neurosci Lett 571:66–71. https://doi.org/10.1016/j.neulet.2014.04.030
Hu C, Zhao YT, Zhang G, Xu MF (2017) Antinociceptive effects of fucoidan in rat models of vincristine-induced neuropathic pain. Mol Med Rep 15(2):975–980. https://doi.org/10.3892/mmr.2016.6071
Hwang JH, Yaksh TL (1997) The effect of spinal GABA receptor agonists on tactile allodynia in a surgically-induced neuropathic pain model in the rat. Pain 70(1):15–22
Ibuki T, Hama AT, Wang XT, Pappas GD, Sagen J (1997) Loss of GABA-immunoreactivity in the spinal dorsal horn of rats with peripheral nerve injury and promotion of recovery by adrenal medullary grafts. Neuroscience 76(3):845–858
Iyadomi M, Iyadomi I, Kumamoto E, Tomokuni K, Yoshimura M (2000) Presynaptic inhibition by baclofen of miniature EPSCs and IPSCs in substantia gelatinosa neurons of the adult rat spinal dorsal horn. Pain 85(3):385–393
Jergova S, Hentall ID, Gajavelli S, Varghese MS, Sagen J (2012) Intraspinal transplantation of GABAergic neural progenitors attenuates neuropathic pain in rats: a pharmacologic and neurophysiological evaluation. Exp Neurol 234(1):39–49. https://doi.org/10.1016/j.expneurol.2011.12.005
Jones KA, Borowsky B, Tamm JA, Craig DA, Durkin MM, Dai M, Yao W-J, Johnson M, Gunwaldsen C, Huang L-Y, Tang C, Shen Q, Salon JA, Morse K, Laz T, Smith KE, Nagarathnam D, Noble SA, Branchek TA, Gerald C (1998) GABAB receptor function as a heteromeric assembly of the subunits GABABR1 and GABABR2. Nature 396:674–679
Jones TL, Sweitzer SM, Peters MC, Wilson SP, Yeomans DC (2005) GABAB receptors on central terminals of C-afferents mediate intersegmental Aδ-afferent evoked hypoalgesia. Eur J Pain 9(3):233–242
Kalinichev M, Donovan-Rodriguez T, Girard F, Haddouk H, Royer-Urios I, Schneider M, Bate ST, Marker C, Pomonis JD, Poli S (2017) ADX71943 and ADX71441, novel positive allosteric modulators of the GABAB receptor with distinct central/peripheral profiles, show efficacy in the monosodium iodoacetate model of chronic osteoarthritis pain in the rat. Eur J Pharmacol 795:43–49. https://doi.org/10.1016/j.ejphar.2016.11.056
Kalinichev M, Donovan-Rodriguez T, Girard F, Riguet E, Rouillier M, Bournique B, Haddouk H, Mutel V, Poli S (2014) Evaluation of peripheral versus central effects of GABAB receptor activation using a novel, positive allosteric modulator of the GABAB receptor ADX71943, a pharmacological tool compound with a fully peripheral activity profile. Br J Pharmacol 171(21):4941–4954. https://doi.org/10.1111/bph.12812
Kannampalli P, Poli SM, Bolea C, Sengupta JN (2017) Analgesic effect of ADX71441, a positive allosteric modulator (PAM) of GABAB receptor in a rat model of bladder pain. Neuropharmacology 126:1–11. https://doi.org/10.1016/j.neuropharm.2017.08.023
Kantamneni S, Gonzalez-Gonzalez IM, Luo J, Cimarosti H, Jacobs SC, Jaafari N, Henley JM (2014) Differential regulation of GABAB receptor trafficking by different modes of N-methyl-D-aspartate (NMDA) receptor signaling. J Biol Chem 289(10):6681–6694. https://doi.org/10.1074/jbc.M113.487348
Kaupmann K, Huggel K, Heid J, Flor PJ, Bischoff S, Mickel SJ, McMaster G, Angst C, Bittiger H, Froestl W, Bettler B (1997) Expression cloning of GABAB receptors uncovers similarity to metabotropic glutamate receptors. Nature 386:239–246
Kaupmann K, Malitschek B, Schuler V, Heid J, Froestl W, Beck P, Mosbacher J, Bischoff S, Kulik A, Shigemoto R, Karshin A, Bettler B (1998) GABAB receptor subtypes assemble into functional heteromeric complexes. Nature 396:683–687
Khan N, Smith MT (2014) Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models. Inflammopharmacology 22(1):1–22. https://doi.org/10.1007/s10787-013-0195-3
Kim SE, Chang L (2012) Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms? Neurogastroenterol Motil 24(10):895–913. https://doi.org/10.1111/j.1365-2982.2012.01993.x
Kopsky DJ, Keppel Hesselink JM, Casale R (2015) Walking with neuropathic pain: paradoxical shift from burden to support? Case Rep Med 2015:764950. https://doi.org/10.1155/2015/764950
Kulik A, Nakadate K, Nyiri G, Notomi T, Malitschek B, Bettler B, Shigemoto R (2002) Distinct localization of GABA(B) receptors relative to synaptic sites in the rat cerebellum and ventrobasal thalamus. Eur J Neurosci 15(2):291–307
Kulik A, Vida I, Fukazawa Y, Guetg N, Kasugai Y, Marker CL, Rigato F, Bettler B, Wickman K, Frotscher M, Shigemoto R (2006) Compartment-dependent colocalization of Kir3.2-containing K+ channels and GABAB receptors in hippocampal pyramidal cells. J Neurosci 26(16):4289–4297
Kulik A, Vida I, Lujan R, Haas CA, Lopez-Bendito G, Shigemoto R, Frotscher M (2003) Subcellular localization of metabotropic GABAB receptor subunits GABAB1a/b and GABAB2 in the rat hippocampus. J Neurosci 23(35):11026–11035
Laffray S, Bouali-Benazzouz R, Papon MA, Favereaux A, Jiang Y, Holm T, Spriet C, Desbarats P, Fossat P, Le Feuvre Y, Decossas M, Heliot L, Langel U, Nagy F, Landry M (2012) Impairment of GABAB receptor dimer by endogenous 14-3-3ζ in chronic pain conditions. EMBO J 31(15):3239–3251. https://doi.org/10.1038/emboj.2012.161
Lambert NA, Wilson WA (1996) High-threshold Ca2+ currents in rat hippocampal interneurones and their selective inhibition by activation of GABAB receptors. J Physiol 492:115–127
Lau BK, Vaughan CW (2014) Descending modulation of pain: the GABA disinhibition hypothesis of analgesia. Curr Opin Neurobiol 29C:159–164. https://doi.org/10.1016/j.conb.2014.07.010
Lee B, Kim J, Kim SJ, Lee H, Chang JW (2007) Constitutive GABA expression via a recombinant adeno-associated virus consistently attenuates neuropathic pain. Biochem Biophys Res Commun 357(4):971–976. https://doi.org/10.1016/j.bbrc.2007.04.061
Lee J, Back SK, Lim EJ, Cho GC, Kim MA, Kim HJ, Lee MH, Na HS (2010) Are spinal GABAergic elements related to the manifestation of neuropathic pain in rat? Korean J Physiol Pharmacol 14(2):59–69. https://doi.org/10.4196/kjpp.2010.14.2.59
Legrain V, Iannetti GD, Plaghki L, Mouraux A (2011) The pain matrix reloaded: a salience detection system for the body. Prog Neurobiol 93(1):111–124. https://doi.org/10.1016/j.pneurobio.2010.10.005
Lever I, Cunningham J, Grist J, Yip PK, Malcangio M (2003) Release of BDNF and GABA in the dorsal horn of neuropathic rats. Eur J Neurosci 18(5):1169–1174
Levy RA, Proudfit HK (1979) Analgesia produced by microinjection of baclofen and morphine at brain stem sites. Eur J Pharmacol 57(1):43–55. https://doi.org/10.1016/0014-2999(79)90102-x
Li G, Shao C, Chen Q, Wang Q, Yang K (2017) Accumulated GABA activates presynaptic GABAB receptors and inhibits both excitatory and inhibitory synaptic transmission in rat midbrain periaqueductal gray. Neuroreport 28(6):313–318. https://doi.org/10.1097/wnr.0000000000000756
Lind G, Schechtmann G, Winter J, Meyerson BA, Linderoth B (2008) Baclofen-enhanced spinal cord stimulation and intrathecal baclofen alone for neuropathic pain: Long-term outcome of a pilot study. Eur J Pain 12(1):132–136
Liu F, Zhang YY, Song N, Lin J, Liu MK, Huang CL, Zhou C, Wang H, Wang M, Shen JF (2019) GABAB receptor activation attenuates inflammatory orofacial pain by modulating interleukin-1beta in satellite glial cells: role of NF-kappaB and MAPK signaling pathways. Brain Res Bull 149:240–250. https://doi.org/10.1016/j.brainresbull.2019.04.018
Liu P, Guo WY, Zhao XN, Bai HP, Wang Q, Wang XL, Zhang YZ (2014) Intrathecal baclofen, a GABAB receptor agonist, inhibits the expression of p-CREB and NR2B in the spinal dorsal horn in rats with diabetic neuropathic pain. Can J Physiol Pharmacol 92(8):655–660. https://doi.org/10.1139/cjpp-2013-0463
Liu P, Yuan HB, Zhao S, Liu FF, Jiang YQ, Guo YX, Wang XL (2018) Activation of GABAB receptor suppresses diabetic neuropathic pain through toll-like receptor 4 signaling pathway in the spinal dorsal horn. Mediators Inflamm 2018:6016272. https://doi.org/10.1155/2018/6016272
Loeza-Alcocer E, McPherson TP, Gold MS (2019) Peripheral GABA receptors regulate colonic afferent excitability and visceral nociception. J Physiol 597(13):3425–3439. https://doi.org/10.1113/jp278025
Luscher C, Jan LY, Stoffel M, Malenka RC, Nicoll RA (1997) G protein-coupled inwardly rectifying K+ channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons. Neuron 19(3):687–695
Magnaghi V, Castelnovo LF, Faroni A, Cavalli E, Caffino L, Colciago A, Procacci P, Pajardi G (2014) Nerve regenerative effects of GABAB ligands in a model of neuropathic pain. Biomed Res Int 2014:368678. https://doi.org/10.1155/2014/368678
Maier PJ, Marin I, Grampp T, Sommer A, Benke D (2010) Sustained glutamate receptor activation down-regulates GABAB receptors by shifting the balance from recycling to lysosomal degradation. J Biol Chem 285(46):35606–35614. https://doi.org/10.1074/jbc.M110.142406
Malan TP, Mata HP, Porreca F (2002) Spinal GABAA and GABAB receptor pharmacology in a rat model of neuropathic pain. Anesthesiology 96(5):1161–1167
Malykhina AP, Wyndaele JJ, Andersson KE, De Wachter S, Dmochowski RR (2012) Do the urinary bladder and large bowel interact, in sickness or in health? ICI-RS 2011. NeurourolUrodyn 31(3):352–358. https://doi.org/10.1002/nau.21228
Martins I, Carvalho P, de Vries MG, Teixeira-Pinto A, Wilson SP, Westerink BH, Tavares I (2015) GABA acting on GABAB receptors located in a medullary pain facilitatory area enhances nociceptive behaviors evoked by intraplantar formalin injection. Pain 156(8):1555–1565. https://doi.org/10.1097/j.pain.0000000000000203
Martins I, Tavares I (2017) Reticular formation and pain: the past and the future. Front Neuroanat 11:51. https://doi.org/10.3389/fnana.2017.00051
May A (2007) Neuroimaging: visualising the brain in pain. Neurol Sci 28(Suppl 2):S101–S107. https://doi.org/10.1007/s10072-007-0760-x
McCarson KE, Enna SJ (1999) Nociceptive regulation of GABAB receptor gene expression in rat spinal cord. Neuropharmacology 38(11):1767–1773
McIntosh JM, Absalom N, Chebib M, Elgoyhen AB, Vincler M (2009) Alpha9 nicotinic acetylcholine receptors and the treatment of pain. Biochem Pharmacol 78(7):693–702. https://doi.org/10.1016/j.bcp.2009.05.020
Melin C, Jacquot F, Dallel R, Artola A (2013) Segmental disinhibition suppresses C-fiber inputs to the rat superficial medullary dorsal horn via the activation of GABAB receptors. Eur J Neurosci 37(3):417–428. https://doi.org/10.1111/ejn.12048
Melzack R, Wall PD (1965) Pain mechanisms: a new theory. Science 150(3699):971–979
Menetrey D, Besson JM (1982) Electrophysiological characteristics of dorsal horn cells in rats with cutaneous inflammation resulting from chronic arthritis. Pain 13(4):343–364
Migita K, Matsuzaki Y, Koga K, Matsumoto T, Mishima K, Hara S, Honda K (2018) Involvement of GABAB receptor in the antihypersensitive effect in anterior cingulate cortex of partial sciatic nerve ligation model. J Pharmacol Sci 137(2):233–236. https://doi.org/10.1016/j.jphs.2018.05.009
Mintz IM, Bean BP (1993) GABAB receptor inhibition of P-type Ca2+ channels in central neurons. Neuron 10(5):889–898
Moore C, Gupta R, Jordt SE, Chen Y, Liedtke WB (2018) Regulation of pain and itch by TRP channels. Neurosci Bull 34(1):120–142. https://doi.org/10.1007/s12264-017-0200-8
Naderi N, Shafaghi B, Khodayar MJ, Zarindast MR (2005) Interaction between gamma-aminobutyric acid GABAB and cannabinoid CB1 receptors in spinal pain pathways in rat. Eur J Pharmacol 514(2-3):159–164. https://doi.org/10.1016/j.ejphar.2005.03.037
Nashawi H, Masocha W, Edafiogho IO, Kombian SB (2016) Paclitaxel causes electrophysiological changes in the anterior cingulate cortex via modulation of the γ-aminobutyric acid-ergic system. Med Princ Pract 25(5):423–428. https://doi.org/10.1159/000447775
Neugebauer V, Li W, Bird GC, Han JS (2004) The amygdala and persistent pain. Neuroscientist 10(3):221–234. https://doi.org/10.1177/1073858403261077
Ng GYK, Clark J, Coulombe N, Ethier N, Hebert TE, Sullivan R, Kargman S, Chateauneuf A, Tsukamoto N, McDonald T, Whiting P, Mezey E, Johnson MP, Liu QY, Kolakowski LF, Evans JF, Bonner TI, O'Neill GP (1999) Identification of a GABAB receptor subunit, gb2, required for functional GABAB receptor activity. J Biol Chem 274(12):7607–7610
Otis TS, De Koninck Y, Mody I (1993) Characterization of synaptically elicited GABAB responses using patch-clamp recordings in rat hippocampal slices. J Physiol 463:391–407
Page AJ, O'Donnell TA, Blackshaw LA (2006) Inhibition of mechanosensitivity in visceral primary afferents by GABAB receptors involves calcium and potassium channels. Neuroscience 137(2):627–636. https://doi.org/10.1016/j.neuroscience.2005.09.016
Patel S, Naeem S, Kesingland A, Froestl W, Capogna M, Urban L, Fox A (2001) The effects of GABAB agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat. Pain 90(3):217–226
Pérez-Garci E, Gassmann M, Bettler B, Larkum ME (2006) The GABAB1b isoform mediates long-lasting inhibition of dendritic Ca2+ spikes in layer 5 somatosensory pyramidal neurons. Neuron 50(4):603–616
Pinto M, Sousa M, Lima D, Tavares I (2008) Participation of mu-opioid, GABAB, and NK1 receptors of major pain control medullary areas in pathways targeting the rat spinal cord: implications for descending modulation of nociceptive transmission. J Comp Neurol 510(2):175–187
Potes CS, Neto FL, Castro-Lopes JM (2006a) Administration of baclofen, a γ-aminobutyric acid type B agonist in the thalamic ventrobasal complex, attenuates allodynia in monoarthritic rats subjected to the ankle-bend test. J Neurosci Res 83(3):515–523. https://doi.org/10.1002/jnr.20737
Potes CS, Neto FL, Castro-Lopes JM (2006b) Inhibition of pain behavior by GABAB receptors in the thalamic ventrobasal complex: effect on normal rats subjected to the formalin test of nociception. Brain Res 1115(1):37–47. https://doi.org/10.1016/j.brainres.2006.07.089
Price GW, Kelly JS, Bowery NG (1987) The location of GABAB receptor binding sites in mammalian spinal cord. Synapse 1(6):530–538. https://doi.org/10.1002/syn.890010605
Price GW, Wilkin GP, Turnbull MJ, Bowery NG (1984) Are baclofen-sensitive GABAB receptors present on primary afferent terminals of the spinal cord? Nature 307(5946):71–74
Reis GM, Duarte ID (2006) Baclofen, an agonist at peripheral GABAB receptors, induces antinociception via activation of TEA-sensitive potassium channels. Br J Pharmacol 149(6):733–739
Ren K, Anseloni V, Zou SP, Wade EB, Novikova SI, Ennis M, Traub RJ, Gold MS, Dubner R, Lidow MS (2004) Characterization of basal and re-inflammation-associated long-term alteration in pain responsivity following short-lasting neonatal local inflammatory insult. Pain 110(3):588–596. https://doi.org/10.1016/j.pain.2004.04.006
Sandkuhler J (2009) Models and mechanisms of hyperalgesia and allodynia. Physiol Rev 89(2):707–758. https://doi.org/10.1152/physrev.00025.2008
Sands SA, McCarson KE, Enna SJ (2003) Differential regulation of GABAB receptor subunit expression and function. J Pharmacol Exp Ther 305(1):191–196
Schreiber AK, Nones CF, Reis RC, Chichorro JG, Cunha JM (2015) Diabetic neuropathic pain: Physiopathology and treatment. World J Diabetes 6(3):432–444. https://doi.org/10.4239/wjd.v6.i3.432
Schuler V, Luscher C, Blanchet C, Klix N, Sansig G, Klebs K, Schmutz M, Heid J, Gentry C, Urban L, Fox A, Spooren W, Jaton AL, Vigouret J, Pozza M, Kelly PH, Mosbacher J, Froestl W, Kaslin E, Korn R, Bischoff S, Kaupmann K, van der Putten H, Bettler B (2001) Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABAB responses in mice lacking GABAB1. Neuron 31(1):47–58
Shaban H, Humeau Y, Herry C, Cassasus G, Shigemoto R, Ciocchi S, Barbieri S, van der Putten H, Kaupmann K, Bettler B, Lüthi A (2006) Generalization of amygdala LTP and conditioned fear in the absence of presynaptic inhibition. Nat Neurosci 9(8):1028–1035
Shafizadeh M, Semnanian S, Zarrindast MR, Hashemi B (1997) Involvement of GABAB receptors in the antinociception induced by baclofen in the formalin test. Gen Pharmacol 28(4):611–615
Slonimski M, Abram SE, Zuniga RE (2004) Intrathecal baclofen in pain management. Reg Anesth Pain Med 29(3):269–276
Smith GD, Harrison SM, Birch PJ, Elliott PJ, Malcangio M, Bowery NG (1994) Increased sensitivity to the antinociceptive activity of (+/−)-baclofen in an animal model of chronic neuropathic, but not chronic inflammatory hyperalgesia. Neuropharmacology 33(9):1103–1108
Soares Potes C, Lourenca Neto F, Manuel Castro-Lopes J (2006) Inhibition of pain behavior by GABAB receptors in the thalamic ventrobasal complex: Effect on normal rats subjected to the formalin test of nociception. Brain Res 1115(1):37–47
Sokal DM, Chapman V (2003) Inhibitory effects of spinal baclofen on spinal dorsal horn neurones in inflamed and neuropathic rats in vivo. Brain Res 987(1):67–75
Somers DL, Clemente FR (2002) Dorsal horn synaptosomal content of aspartate, glutamate, glycine and GABA are differentially altered following chronic constriction injury to the rat sciatic nerve. Neurosci Lett 323(3):171–174. https://doi.org/10.1016/s0304-3940(02)00157-x
Steiger JL, Bandyopadhyay S, Farb DH, Russek SJ (2004) cAMP response element-binding protein, activating transcription factor-4, and upstream stimulatory factor differentially control hippocampal GABABR1a and GABABR1b subunit gene expression through alternative promoters. J Neurosci 24:6115–6126
Taira T, Hori T (2007) Intrathecal baclofen in the treatment of post-stroke central pain, dystonia, and persistent vegetative state. Acta Neurochir Suppl 97(Pt 1):227–229
Taira T, Kawamura H, Tanikawa T, Iseki H, Kawabatake H, Takakura K (1995) A new approach to control central deafferentation pain: spinal intrathecal baclofen. Stereotact Funct Neurosurg 65(1–4):101–105
Takazawa T, Choudhury P, Tong CK, Conway CM, Scherrer G, Flood PD, Mukai J, MacDermott AB (2017) Inhibition mediated by glycinergic and GABAergic receptors on excitatory neurons in mouse superficial dorsal horn is location-specific but modified by inflammation. J Neurosci 37(9):2336–2348. https://doi.org/10.1523/jneurosci.2354-16.2017
Takeda M, Nasu M, Kanazawa T, Shimazu Y (2015) Activation of GABAB receptors potentiates inward rectifying potassium currents in satellite glial cells from rat trigeminal ganglia: in vivo patch-clamp analysis. Neuroscience 288:51–58. https://doi.org/10.1016/j.neuroscience.2014.12.024
Takeda M, Takahashi M, Matsumoto S (2009) Contribution of the activation of satellite glia in sensory ganglia to pathological pain. Neurosci Biobehav Rev 33(6):784–792. https://doi.org/10.1016/j.neubiorev.2008.12.005
Terunuma M, Vargas KJ, Wilkins ME, Ramirez OA, Jaureguiberry-Bravo M, Pangalos MN, Smart TG, Moss SJ, Couve A (2010) Prolonged activation of NMDA receptors promotes dephosphorylation and alters postendocytic sorting of GABAB receptors. Proc Natl Acad Sci U S A 107(31):13918–13923
Todd AJ (2010) Neuronal circuitry for pain processing in the dorsal horn. Nat Rev Neurosci 11(12):823–836. https://doi.org/10.1038/nrn2947
Towers S, Princivalle A, Billinton A, Edmunds M, Bettler B, Urban L, Castro-Lopes J, Bowery NG (2000) GABAB receptor protein and mRNA distribution in rat spinal cord and dorsal root ganglia. Eur J Neurosci 12(9):3201–3210
Tsuda M, Mizokoshi A, Shigemoto-Mogami Y, Koizumi S, Inoue K (2004) Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 45(1):89–95. https://doi.org/10.1002/glia.10308
Urwyler S (2011) Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives. Pharmacol Rev 63(1):59–126. https://doi.org/10.1124/pr.109.002501
van der Plas AA, van Rijn MA, Marinus J, Putter H, van Hilten JJ (2013) Efficacy of intrathecal baclofen on different pain qualities in complex regional pain syndrome. Anesth Analg 116(1):211–215. https://doi.org/10.1213/ANE.0b013e31826f0a2e
Vaysse L, Sol JC, Lazorthes Y, Courtade-Saidi M, Eaton MJ, Jozan S (2011) GABAergic pathway in a rat model of chronic neuropathic pain: modulation after intrathecal transplantation of a human neuronal cell line. Neurosci Res 69(2):111–120. https://doi.org/10.1016/j.neures.2010.10.006
Vigot R, Barbieri S, Bräuner-Osborne H, Turecek R, Shigemoto R, Zhang YP, Lujan R, Jacobson LH, Biermann B, Fritschy JM, Vacher CM, Müller M, Sansig G, Guetg N, Cryan JF, Kaupmann K, Gassmann M, Oertner TG, Bettler B (2006) Differential compartmentalization and distinct functions of GABAB receptor variants. Neuron 50(4):589–601
Wang N, Zhang T, Su YL, Wang JY, Luo F (2016) Differential modulation of electrical stimulation of periaqueductal gray and thalamus on nociceptive behaviors of rats. Sheng Li Xue Bao 68(2):115–125
Wang XL, Zhang HM, Chen SR, Pan HL (2007) Altered synaptic input and GABAB receptor function in spinal superficial dorsal horn neurons in rats with diabetic neuropathy. J Physiol 579(Pt 3):849–861. https://doi.org/10.1113/jphysiol.2006.126102
Wang XL, Zhang Q, Zhang YZ, Liu YT, Dong R, Wang QJ, Guo YX (2011) Downregulation of GABAB receptors in the spinal cord dorsal horn in diabetic neuropathy. Neurosci Lett 490(2):112–115. https://doi.org/10.1016/j.neulet.2010.12.038
Wang Y, Xing M, Cao Q, Ji A, Liang H, Song S (2019) Biological activities of fucoidan and the factors mediating its therapeutic effects: A review of recent studies. Mar Drugs 17(3):E183. https://doi.org/10.3390/md17030183
White JH, Wise A, Main MJ, Green A, Fraser NJ, Disney GH, Barnes AA, Emson P, Foord SM, Marshall FH (1998) Heterodimerization is required for the formation of functional GABAB receptors. Nature 396:679–682
White K, Targett M, Harris J (2018) Gainfully employing descending controls in acute and chronic pain management. Vet J 237:16–25. https://doi.org/10.1016/j.tvjl.2018.05.005
Whitehead RA, Puil E, Ries CR, Schwarz SK, Wall RA, Cooke JE, Putrenko I, Sallam NA, Macleod BA (2012) GABAB receptor-mediated selective peripheral analgesia by the non-proteinogenic amino acid, isovaline. Neuroscience 213:154–160. https://doi.org/10.1016/j.neuroscience.2012.04.026
Wu J, Xu Y, Pu S, Jiang W, Du D (2011) p38/MAPK inhibitor modulates the expression of dorsal horn GABAB receptors in the spinal nerve ligation model of neuropathic pain. Neuroimmunomodulation 18(3):150–155. https://doi.org/10.1159/000323141
Yam MF, Loh YC, Tan CS, Khadijah Adam S, Abdul Manan N, Basir R (2018) General pathways of pain sensation and the major neurotransmitters involved in pain regulation. Int J Mol Sci 19(8):E2164. https://doi.org/10.3390/ijms19082164
Yang K, Furue H, Kumamoto E, Dong YX, Yoshimura M (2003) Pre- and postsynaptic inhibition mediated by GABAB receptors in rat ventrolateral periaqueductal gray neurons. Biochem Biophys Res Commun 302(2):233–237. https://doi.org/10.1016/s0006-291x(03)00156-6
Yang K, Ma H (2011) Blockade of GABAB receptors facilitates evoked neurotransmitter release at spinal dorsal horn synapse. Neuroscience 193:411–420. https://doi.org/10.1016/j.neuroscience.2011.07.033
Yang K, Ma R, Wang Q, Jiang P, Li YQ (2015) Optoactivation of parvalbumin neurons in the spinal dorsal horn evokes GABA release that is regulated by presynaptic GABAB receptors. Neurosci Lett 594:55–59. https://doi.org/10.1016/j.neulet.2015.03.050
Yang K, Wang D, Li YQ (2001) Distribution and depression of the GABAB receptor in the spinal dorsal horn of adult rat. Brain Res Bull 55(4):479–485
Zeilhofer HU, Benke D, Yevenes GE (2012a) Chronic pain states: pharmacological strategies to restore diminished inhibitory spinal pain control. Annu Rev Pharmacol Toxicol 52:111–133. https://doi.org/10.1146/annurev-pharmtox-010611-134636
Zeilhofer HU, Wildner H, Yevenes GE (2012b) Fast synaptic inhibition in spinal sensory processing and pain control. Physiol Rev 92(1):193–235
Zemoura K, Balakrishnan K, Grampp T, Benke D (2019) Ca2+/Calmodulin-dependent protein kinase II (CaMKII) β-dependent phosphorylation of GABAB1 triggers lysosomal degradation of GABAB Receptors via mind bomb-2 (MIB2)-mediated Lys-63-linked ubiquitination. Mol Neurobiol 56(2):1293–1309. https://doi.org/10.1007/s12035-018-1142-5
Zemoura K, Ralvenius WT, Malherbe P, Benke D (2016) The positive allosteric GABAB receptor modulator rac-BHFF enhances baclofen-mediated analgesia in neuropathic mice. Neuropharmacology 108:172–178. https://doi.org/10.1016/j.neuropharm.2016.04.028
Zheng J, Lu Y, Perl ER (2010) Inhibitory neurones of the spinal substantia gelatinosa mediate interaction of signals from primary afferents. J Physiol 588(Pt 12):2065–2075. https://doi.org/10.1113/jphysiol.2010.188052
Zhou YQ, Chen SP, Liu DQ, Manyande A, Zhang W, Yang SB, Xiong BR, Fu QC, Song ZP, Rittner H, Ye DW, Tian YK (2017) The role of spinal GABAB receptors in cancer-induced bone pain in rats. J Pain 18(8):933–946. https://doi.org/10.1016/j.jpain.2017.02.438
Zuniga RE, Schlicht CR, Abram SE (2000) Intrathecal baclofen is analgesic in patients with chronic pain. Anesthesiology 92(3):876–880
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Benke, D. (2020). GABAB Receptors and Pain. In: Vlachou, S., Wickman, K. (eds) Behavioral Neurobiology of GABAB Receptor Function. Current Topics in Behavioral Neurosciences, vol 52. Springer, Cham. https://doi.org/10.1007/7854_2020_130
Download citation
DOI: https://doi.org/10.1007/7854_2020_130
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-91334-2
Online ISBN: 978-3-030-91335-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)